Bank of America’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bank of America’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,200	Closed	-$428K	–	7206
2014 Q4	$428K	Sell	4,200 -7,400	-64%	-$723K	﹤0.01%	4754
2014 Q3	$1.06M	Buy	11,600 +3,000	+35%	+$260K	﹤0.01%	3944
2014 Q2	$708K	Sell	8,600 -5,700	-40%	-$436K	﹤0.01%	4302
2014 Q1	$1.1M	Sell	14,300 -37,400	-72%	-$2.92M	﹤0.01%	3796
2013 Q4	$3.58M	Buy	51,700 +17,500	+51%	+$1.15M	﹤0.01%	2773
2013 Q3	$2.22M	Buy	34,200 +26,300	+333%	+$1.66M	﹤0.01%	3173
2013 Q2	$460K	Buy	+7,900	New	+$451K	﹤0.01%	4831

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Bank of America's FBT Position: Q1 2026 in Review

Bank of America increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 5.7% in Q1 2026, buying an estimated $2.24M and bringing the position to 200,959 shares worth $40.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

Bank of America first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $152M in Q1 2019. 308 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Bank of America held 200,959 shares of First Trust NYSE Arca Biotechnology Index Fund worth $40.4M as of Q1 2026.
Bank of America bought 10,853 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.24M.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1762 holding.
Bank of America first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
Bank of America's First Trust NYSE Arca Biotechnology Index Fund position peaked at $152M in Q1 2019.
308 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.